Product Information
KONVOMEP 2-84 MG/ML ORAL SUSP is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $1.2519 per ML under NDC 65628027210. Its NADAC has been published 154 times since Jul 19, 2023.
Manufacturer
Azurity Pharmaceuticals Inc.NDC
65628027210
Classification
Brand
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
New Drug (NDA)
FDA Application
NDA213593On Market Since
2/15/2023
Price Statistics
The NADAC for KONVOMEP 2-84 MG/ML ORAL SUSP has been published 154 times since Jul 19, 2023, and over the history we have for it it has risen 13.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2519 per ML |
|---|---|
| All-time high | $1.2519 (Jun 24, 2026) |
| All-time low | $1.1001 (Jul 19, 2023) |
| 52-week high | $1.2519 |
| 52-week low | $1.2110 |
| Median price | $1.1261 |
| Average price | $1.1702 |
| Largest weekly change | +9.0% (Jan 15, 2025) |
| Weeks tracked | 154 |
| Tracking since | Jul 19, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of KONVOMEP 2-84 MG/ML ORAL SUSP?
The current National Average Drug Acquisition Cost (NADAC) for KONVOMEP 2-84 MG/ML ORAL SUSP, manufactured by Azurity Pharmaceuticals Inc., is $1.2519 per ML (NDC 65628027210), effective Jun 24, 2026.
How has the price of KONVOMEP 2-84 MG/ML ORAL SUSP changed over time?
Over the history we have for it, the NADAC for KONVOMEP 2-84 MG/ML ORAL SUSP has risen 13.8%. It has been tracked across 154 weekly CMS publications since Jul 19, 2023.
What are the highest and lowest recorded NADAC prices for KONVOMEP 2-84 MG/ML ORAL SUSP?
Since Jul 19, 2023, the NADAC for KONVOMEP 2-84 MG/ML ORAL SUSP has ranged from a low of $1.1001 (Jul 19, 2023) to a high of $1.2519 (Jun 24, 2026), with a median of $1.1261 per ML.
Are there cheaper alternatives to KONVOMEP 2-84 MG/ML ORAL SUSP?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as KONVOMEP 2-84 MG/ML ORAL SUSP, but none are currently priced below it.
Who manufactures KONVOMEP 2-84 MG/ML ORAL SUSP?
KONVOMEP 2-84 MG/ML ORAL SUSP (NDC 65628027210) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification